Cargando…
In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine
With the onset of Coronavirus disease 2019 (COVID-19) pandemic, all attention was drawn to finding solutions to cure the coronavirus disease. Among all vaccination strategies, the nanoparticle vaccine has been shown to stimulate the immune system and provide optimal immunity to the virus in a single...
Autores principales: | Masoomi Nomandan, Seyedeh Zeinab, Azimzadeh Irani, Maryam, Hosseini, Seyed Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486171/ https://www.ncbi.nlm.nih.gov/pubmed/36148012 http://dx.doi.org/10.3389/fmolb.2022.976490 |
Ejemplares similares
-
Structural arrangement of the active back-to-back dimer in N-glycosylated ErbB receptors is regulated by heterodimerization
por: Mashayekh-Poul, Romina, et al.
Publicado: (2023) -
Editorial: Characterization, Biosynthesis and Biological Functions of Novel Glyco-Epitopes
por: Yan, Shi, et al.
Publicado: (2022) -
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021) -
Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021) -
Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
por: Zhang, Rutan, et al.
Publicado: (2021)